drugset / Trial / NCT02311855

Duration of Immune Response to Influenza Vaccination in Patients With RA

NCT02311855

NaSingle-groupOpen-labelBasic science

Summary

The main objective is to evaluate the strength and duration of immune response after influenza vaccination in patients with Rheumatoid Arthritis (RA) receiving treatment with biological agents as compared to a group healthy controls who do not have RA. Influenza vaccine titers will be drawn 3 times: at Baseline(prior to vaccination), 4-6 weeks post vaccination, and 5-6 months post vaccination. Influenza vaccination will be done at the baseline visit after the baseline blood draw.

Timeline

Start
2014-08
Primary completion
2015-12
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular

Indications